59 results match your criteria: "University Hospital Ferrara[Affiliation]"
PLoS One
November 2020
Unit of Medical Genetics, University Hospital Ferrara, Ferrara, Italy.
The genetic diagnostics of inherited neuromuscular diseases (NMDs) is challenging due to their clinical and genetic heterogeneity. We launched an online survey within the EURO-NMD European Reference Network (ERN) to collect information about the availability/distribution of genetic testing across 61 ERN health care providers (HCPs). A 17 items questionnaire was designed to address methods used, the number of genetic tests available, the clinical pathway to access genetic testing, the use of next-generation sequencing (NGS) and participation to quality assessment schemes (QAs).
View Article and Find Full Text PDFActa Neurol Belg
December 2020
Neurosurgery Division, M. Bufalini Hospital, Viale Ghirotti 286, 47521, Cesena, Italy.
World Neurosurg
November 2020
Department of Neurosurgery, Maria Cecilia Hospital, GVM Care & Research, Cotignola (Ravenna), Italy.
Background: Choroid plexus cysts (CPCs) are a type of neuroepithelial cysts, benign lesions located more frequently in the supratentorial compartment. Symptomatic CPCs in the posterior fossa are extremely rare and can be associated with obstructive hydrocephalus.
Case Description: A previously healthy elderly woman suffered intermittent attacks of headache and vomiting associated with gait instability.
Curr Med Chem
August 2020
Department of Morphology, Surgery and Experimental Medicine, Section of Pathology, Oncology and Experimental Biology, Laboratory for Technologies of Advanced Therapies (LTTA), University of Ferrara, Ferrara, Italy.
Glioblastoma multiforme (GBM) is characterized by poor prognosis despite an aggressive therapeutic strategy. In recent years, many advances have been achieved in the field of glioblastoma biology. Here we try to summarize the main clinical and biological factors impacting clinical prognostication and therapy of GBM patients.
View Article and Find Full Text PDFOral Oncol
November 2019
Radiation Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Italy.
Re-irradiation is becoming an established treatment option for recurrent or second primary head and neck cancer(HNC). However, acute and long-term RT-related toxicities could dramatically impact patients' quality of life. Due to the sparse literature regarding HNC re-irradiation, data on tolerance doses for various organs at risk (OARs) are scarce.
View Article and Find Full Text PDFActa Neurol Belg
October 2020
Neurosurgery, Sant'Anna University Hospital Ferrara, Via Aldo Moro 8, 8-44124, Cona, FE, Italy.
Catheter Cardiovasc Interv
December 2019
Interventional Cardiology Department, University Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
Background: Long-term outcomes of diabetic patients suffering from ST-segment elevation myocardial infarction (STEMI) and treated with second-generation drug-eluting stent have been scarcely evaluated. The aim of this posthoc subanalysis of the EXAMINATION trial was to compare 5-year outcomes according to the presence of diabetes mellitus.
Methods: From a total of 1,497 patients included in the trial, 258 were diabetics (n = 137, received everolimus-eluting stent (EES) and n = 121 bare-metal stent (BMS); whereas 1,239 were nondiabetics (n = 613 treated with EES and n = 626 with BMS).
Biomed Res Int
April 2019
Neurosurgery, Sant'Anna University Hospital Ferrara, Via Aldo Moro 8, Cona (FE), Italy.
Models of cerebrospinal fluid (CSF) circulation have been mainly proposed in the last century: CSF goes from the ventricles to the subarachnoidal space (SAS), passing through the aqueduct and the foramen of Luschka and Magendie. Indeed, new models, involving the Virchow-Robin space (VRS) and the perivascular space (PVS), have been proposed. We critically reviewed the literature, in order to clarify the "classical" errors and to discuss the "new" models that are evolving currently.
View Article and Find Full Text PDFLaryngoscope Investig Otolaryngol
August 2018
the Division for Endocrine Surgery, Department of Human Pathology in Adulthood and Childhood "G. Barresi" University Hospital G. Martino, University of Messina Messina Italy.
Background: The increasing use of intraoperative neuromonitoring (IONM) in thyroid surgery has revealed the need to develop new strategies for cases in which a loss of signal (LOS) occurs on the first side of a planned total thyroidectomy.
Objectives: This study reviews the experience of the authors in using IONM for planned total thyroidectomy after LOS on the first thyroid lobe. The aims were to estimate the incidence of LOS on the first side of resection and to compare intraoperative strategies applied after this event.
PLoS One
January 2019
University Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
Background: Use of everolimus-eluting stents (EES) has proven to be clinically effective and safe in patients with ST-segment elevation myocardial infarction but it remains unclear whether it is cost-effective compared to bare-metal stents (BMS) in the long-term. We sought to assess the cost-effectiveness of EES versus BMS based on the 5-year results of the EXAMINATION trial, from a Spanish health service perspective.
Methods: Decision analysis of the use of EES versus BMS was based on the patient-level clinical outcome data of the EXAMINATION trial.
Strahlenther Onkol
December 2018
Otorhinolaryngology-Audiology-Phoniatric Unit, University Hospital Cisanello, Via Paradisa 2, Pisa, Italy.
Background And Purpose: A prospective instrumental assessment of late dysphagia using swallowing organs at risk (SWOARs)-sparing IMRT for nasopharyngeal and oropharyngeal cancers.
Materials And Methods: Objective instrumental assessment included fiberoptic endoscopic evaluation of swallowing (FEES) and videofluoroscopy (VFS) at baseline, and at 6 and 12 months after treatment. FEES assessed the pharyngeal residue according to the Farneti pooling score (P-score) as follows: 4-5 no dysphagia; 6-7 mild dysphagia; 8-9 moderate dysphagia; 10-11 severe dysphagia.
J Gastrointest Cancer
September 2019
Department of Morphology, Experimental Medicine and Surgery, Section of General and Thoracic Surgery, University of Ferrara, Ferrara, Italy.
Background: Colorectal cancer is the third most prevalent cancer in the world, preceded by prostate and lung cancers in men (10%) and breast and lung cancers in women (9.4%). Colorectal cancer is the fourth leading cause of death in men (7.
View Article and Find Full Text PDFOncotarget
February 2018
Division of Medical Oncology A, National Cancer Institute (CRO), Aviano (PN), Italy.
Background: Although several studies have been carried out to determine the best treatment for gastric carcinoma, the data on survival rate still remain inconclusive.
Objective: To evaluate the effects of postoperative radio-chemotherapy on overall and disease-free survival.
Data Sources: MEDLINE and CANCERLIT searches of reference lists (for the period 1970 to 2016) were supplemented with hand search of reference lists.
J Gastrointest Cancer
March 2019
Division of Medical Oncology A, National Cancer Institute, IRCCS, Aviano, PN, Italy.
Background: Locally advanced rectal cancer is usually treated with a preoperative approach with radiochemotherapy followed by surgery. Patients obtaining a pathologic complete response have a very favorable long-term prognosis. This study was intended to assess whether major surgery can reduce tumor recurrences and prolong survival of patients with a complete response after radiochemotherapy.
View Article and Find Full Text PDFRadiother Oncol
January 2018
Department of Medical Oncology, Centro di Riferimento Oncologico of Aviano, Italy.
Background And Purpose: We conducted a prospective phase II multicentric trial to determine if radical radiation therapy to all metastatic sites might improve the progression-free survival (PFS) in oligometastatic breast cancer patients. Secondary endpoints were local control (LC), overall survival (OS) and toxicity.
Methods And Materials: Inclusion criteria were the following: oligometastatic breast cancer with ≤5 metastatic sites, FDG-PET/CT staging, no brain metastases, primary tumor controlled.
Eur J Vasc Endovasc Surg
September 2017
Department of Vascular Surgery, Policlinico di Monza, Via Amati 111, 20900 Monza, Italy.
Eur J Vasc Endovasc Surg
May 2017
Department of Vascular Surgery, Policlinico di Monza, Via Amati 111, 20900 Monza, Italy.
Objective/background: Several plaque and lesion characteristics have been associated with an increased risk for procedural stroke during or shortly after carotid artery stenting (CAS). While technical advancements in stent design and cerebral protection devices (CPD) may help reduce the procedural stroke risk, and anatomy remains important, tailoring stenting procedures according to plaque and lesion characteristics might be a useful strategy in reducing stroke associated with CAS. In this descriptive report of the ongoing Asymptomatic Carotid Surgery Trial-2 (ACST-2), it was assessed whether choice for stent and use or type of CPD was influenced by plaque and lesion characteristics.
View Article and Find Full Text PDFOncotarget
April 2017
Division of Medical Oncology, Department of Uro-Gynaecological Oncology, Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale", Naples, Italy.
Introduction: Complementary and Alternative Medicine (CAM) include a wide range of products (herbs, vitamins, minerals, and probiotics) and medical practices, developed outside of the mainstream Western medicine. Patients with cancer are more likely to resort to CAM first or then in their disease history; the potential side effects as well as the costs of such practices are largely underestimated.
Patients And Method: We conducted a descriptive survey in five Italian hospitals involving 468 patients with different malignancies.
Eur J Cancer Prev
January 2017
aDepartment of Public Health, Area Vasta Emilia Centrale Cancer Registry, Ferrara Local Health Unit bDepartment of Morphology, Surgery and Experimental Medicine, University of Ferrara, Ferrara cDepartment of Public Health, Area Vasta Emilia Centrale Cancer Registry, Bologna Local Health Unit, Bologna dClinical Oncology Unit, Department of Specialty Medicine, University Hospital Ferrara, Ferrara, Italy eDepartment of Biostatistics, University Hospital of Lyon fUniversity of Lyon, Lyon gUniversity of Lyon 1 hCNRS, UMR 5558,Biometry and Evolutionary Biology Laboratory (LBBE), BioMaths-Health Department iFrench Network of Cancer Registries (Francim), Toulouse jBas-Rhin Cancer Registry, Department of Epidemiology and Public Health, EA 3430, Faculty of Medicine, University of Strasbourg kDepartment of Public Health, University Hospital of Strasbourg, Strasbourg lRegistre Bourguignon des Cancers Digestifs, CHU de Dijon; INSERM U 866; University of Burgundy, Dijon, France mRegistro Tumori del Canton Ticino, Istituto cantonale di patologia, Locarno, Switzerland.
Liver cancer represents a major clinical challenge. The aim of the SUDCAN collaborative study was to compare the net survival from liver cancer between six European Latin countries (Belgium, France, Italy, Portugal, Spain and Switzerland) and provide trends in net survival and dynamics of excess mortality rates (EMRs) up to 5 years after diagnosis. The data were extracted from the EUROCARE-5 database.
View Article and Find Full Text PDFEur J Hosp Pharm
January 2016
Department of Clinical Pharmacy, Mediterranean Institute for Transplantation and Advanced Specialised Therapies (ISMETT), Palermo, Italy.
Lancet
January 2016
International Centre of Circulatory Health, Imperial College London, London, UK.
Background: Data for the safety and efficacy of new-generation drug-eluting stents at long-term follow-up, and specifically in patients with ST-segment elevation myocardial infarction, are scarce. In the EXAMINATION trial, we compared everolimus-eluting stents (EES) with bare-metal stents (BMS) in an all-comer population with ST-segment elevation myocardial infarction. In this study, we assessed the 5-year outcomes of the population in the EXAMINATION trial.
View Article and Find Full Text PDFCurr Drug Targets
October 2016
Eye Clinic, S. Anna University Hospital - Ferrara, Italy.
Retinal vein occlusion (RVO) is the second most common cause of visual loss in the Western World. RVO is usually classified into branch RVO (BRVO) and central RVO (CRVO) according to the anatomical site of the vascular occlusion. The pathogenesis of RVO is not yet fully understood, however an important event is the intraluminal thrombus formation, which is usually secondary to several conditions such as hypertension, hyperlipidemia, diabetes and thrombophilia.
View Article and Find Full Text PDFInflamm Bowel Dis
February 2015
*Department of Gastroenterology, Telemark Hospital, Skien, Norway; †Department of Gastroenterology, Oslo University Hospital Ullevål, Oslo, Norway; ‡Department of Medicine, Gentofte Hospital, Hellerup, Denmark; §Department of Gastroenterology and Hepatology, Ben Gurion University and Soroka Medical Center, Beer Sheva, Israel; ‖Department of Biostatistics, Oslo University Hospital, Oslo, Norway; ¶Department of Internal Medicine, University Hospital Ferrara, Ferrara, Italy; and **Department for Research and Development, Telemark Hospital, Skien, Norway.
Background: Chronic inflammatory bowel disease (IBD) negatively affects the patient's health-related quality of life (HRQoL). Only a few population-based studies have compared the HRQoL of patients with the background population. The aim of this study was to evaluate the HRQoL in a European cohort of patients with ulcerative colitis and Crohn's disease 10 years after diagnosis (European Collaborative study group of Inflammatory Bowel Disease) compared with the national background population in each country and to assess possible country-specific differences.
View Article and Find Full Text PDF